Importantly, SIRT1-dependent control of Th9 cells differentiation appears to have a key role on anti-tumor immunity and allergic pulmonary inflammation [47], suggesting that targeting sirtuins could be exploited as potential therapies for inflammatory and autoimmune diseases. This evidence concerns the gene SIRT1 and neoplasm.